JUNSHI BIO (01877) Releases February 2026 Monthly Return on Securities Movements

Bulletin Express17:47

Shanghai Junshi Biosciences Co., Ltd. (01877) announced that as of 28 February 2026, the registered share capital remained at RMB 1.03 billion. The total number of H shares stood at 260.30 million, and the total number of A shares (listed on the STAR Market) remained at 766.39 million.

No new shares were issued, and no treasury shares were cancelled or transferred during the period. For H shares, 13.21 million share options were outstanding under the existing incentive scheme; for A shares, 24.70 million share options were outstanding. There was no change in treasury share balances, and no funds were raised from any option exercises in February 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment